tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us
TipRanksTop Financial ExpertsInsidersThomas Dolca

Thomas Dolca Insider Profile

4 Followers
Thomas Dolca, CMO at Principia Biopharma, holds 0.00 shares in Chinook Therapeutics (Ticker: KDNY), holds 0.00 shares in Principia Biopharma (Ticker: PRNB), holds ― shares in Equillium (Ticker: EQ).
See the Hottest Stocks Based on Insider Trading >
tipranks
Thomas Dolca

Thomas Dolca
Principia Biopharma (PRNB)
CMO

Not Ranked
Thomas Dolca has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark
How are Insiders Ranked?

Insider Holdings

Thomas Dolca does not currently own shares as a corporate insider.
A breakdown of Thomas Dolca's holdings
See the Top Stocks by Insiders

Insider Roles

Equillium
(EQ)
Chief Medical Officer
Allakos
(ALLK)
Director
Roles that Thomas Dolca holds in companies
See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:
Chinook Therapeutics
(KDNY)
Rating:Informative Buy
Date:Sep 06, 2022 - Sep 06, 2023
Return:+98.40%
The most profitable trade made by Thomas Dolca
See the Latest Stocks Traded by Insiders

Thomas Dolca's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
PRNB
Principia Biopharma
Sep 28, 2020
―
Uninformative Sell
220.70K
$0.00
KDNY
Chinook Therapeutics
Aug 11, 2023
―
Uninformative Sell
―
$0.00
EQ
Equillium
―
Chief Medical Officer
―
―
ALLK
Allakos
―
Director
―
―
List of latest transactions for each holding click on a transaction to see Thomas Dolca's performance on stock
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

Thomas Dolca insider profile FAQ

What is the percentage of profitable transactions made by Thomas Dolca?
The percentage of profitable transactions made by Thomas Dolca is ―.
    What is the average return per transaction made by Thomas Dolca?
    The average return per transaction made by Thomas Dolca is ―.
      What stocks does Thomas Dolca hold?
      Thomas Dolca holds: PRNB, KDNY, EQ, ALLK stocks.
        What was Thomas Dolca’s latest transaction?
        Thomas Dolca latest transaction was an Uninformative Sell of ―.
          What was Thomas Dolca's most profitable transaction?
          Thomas Dolca’s most profitable transaction was an Informative Buy of KDNY stock on September 6, 2022. The return on the trade was 98.40%.
            What is Thomas Dolca's role in Principia Biopharma?
            Thomas Dolca's role in Principia Biopharma is CMO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.